Koers Repro-Med Systems, Inc. OTC Bulletin Board
Aandelen
US7599101026
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 31,75 mln. 29,4 mln. | Omzet 2025 * | 37,64 mln. 34,85 mln. | Marktkapitalisatie | 102 mln. 94,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -7 mln. -6,48 mln. | Nettowinst (verlies) 2025 * | -4 mln. -3,7 mln. | EV/omzet 2024 * | 3,2 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,7 x |
K/w-verhouding 2024 * |
-14,1
x | K/w-verhouding 2025 * |
-26,4
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 87,12% |
Recentste transcriptie over Repro-Med Systems, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Linda Tharby
CEO | Chief Executive Officer | 56 | 12-04-21 |
Thomas Adams
DFI | Director of Finance/CFO | 52 | 01-11-21 |
Brent Rutland
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Cascella
BRD | Director/Board Member | 69 | 01-01-22 |
R. Fletcher
CHM | Chairman | 78 | 07-05-19 |
Edward Wholihan
BRD | Director/Board Member | 64 | 28-09-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,26% | 187 mld. | |
+2,05% | 110 mld. | |
-1,31% | 69,54 mld. | |
+14,65% | 46,37 mld. | |
-6,69% | 46,05 mld. | |
+7,97% | 42,54 mld. | |
+18,60% | 30,72 mld. | |
+16,92% | 25,62 mld. | |
-6,87% | 23,32 mld. |